BR
BrainsWay Ltd.
BRSYF · OTC
$12.60 -16.72% (-$2.53)
Market Cap $607.2M
P/E Ratio 64.03x
Div. Yield -
ROE 12.71%
Bulios Fair Price
$12.34
2.1% downside
Current Price
$12.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BRSYF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
10 /100
Expensive P/E 64.03x
EV/EBITDA 47.80x
PEG 0.40x
Growth
100 /100
Growing Rev. growth 27.65%
Book val. growth 17.28%
EPS growth N/A
Profitability
72 /100
Strong Gross margin 75.33%
Net margin 15.65%
FCF margin 9.48%
Quality
52 /100
Average ROIC 7.70%
ROE 12.71%
Asset turnover 0.50x
Debt
91 /100
Low Debt/Equity 0.09x
Current ratio 3.59x
Net debt/EBITDA -4.79x
Stability
43 /100
Moderate Beta 0.15x
Rev. volatility 10.48%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BRSYF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hadar Levy
Employees
129
Headquarters
Jerusalem
Upcoming events
10 NOV
Earnings
Upcoming earnings report